Advertisement

Topics

SurModics Company Profile

16:06 EST 17th November 2017 | BioPortfolio

Our Mission To enhance the well-being of our clients and their customers by providing the world's foremost innovative surface-modification technologies and related products. Our Guiding Principles Scientific Excellence We are committed to the highest standards of scientific excellence, innovation and integrity. We engage in leading-edge research in order to continuously develop creative, effective and beneficial products. We strive to apply superior problem-solving capabilities and sound judgment in all that we do. Industry Leader We are committed to being an industry leader in all markets we serve. We strive to continuously improve our products, processes and services. We must aggressively compete for market share and take the necessary initiatives to capitalize on opportunities we identify and choose to pursue. Customer Relationships We are committed to understand and anticipate the changing needs of our customers, and we strive to exceed their expectations. We regard clients as partners and as such strive to add to their success. We recognize that mutual success can evolve through a spirit of partnership. Responsibility, Collaboration and Performance We are committed to building a culture that fosters integrity, commercial honor, open communication, mutual respect and an appreciation of personal contribution. We believe that success emanates from team efforts and requires strong leadership and individual accountability. We reward high performance, sound decisions and creativity. We celebrate successes. Community Involvement We are committed to supporting our extended communities. We believe that employees are integral to the well-being of SurModics, their families and communities. We are committed to the safety of employees and will protect the environments in which we operate. Success We are committed to creating long-term value for SurModics shareholders. We believe that adhering to these guiding principles will contribute to the ongoing success of our company, employees, clients and shareholders.

Location

9924 West 74th Street
Eden Prairie
Minnesota
55344-3523
United States of America

Contact

Phone: 1-866-SURMODX or 952-829-2700
Fax: 952-829-2743
Email: info@surmodics.com


News Articles [21 Associated News Articles listed on BioPortfolio]

Surmodics's next-gen drug-coated balloon gets IDE from FDA

Surmodics has obtained an investigational device exemption from the FDA to conduct a pivotal clinical trial of its SurVeil dr -More- 

FDA, EU clear SurModics' low-profile PTA balloon dilation catheter

The FDA gave SurModics 510(k) clearance for its 0.014-inch low-profile percutaneous transluminal angioplasty balloon dilation -More- 

Study begins for Surmodics' SurVeil drug-coated balloon

The first patient in a pivotal clinical trial of the SurVeil drug-coated balloon has been enrolled by Surmodics.  -More- 

Surmodics secures IDE approval to start trial of SurVeil drug-coated balloon

Surmodics has received an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a pivotal clinical trial of the SurVeil™ drug-coated balloon (DCB).

Surmodics to Present at Canaccord Genuity Medical Technologies and Diagnostics Forum

Webcast is Live on Thursday, November 9, at 9 a.m. (ET) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health...

SurModics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 12062017] Prices from USD $350

SurModics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's SurModics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report inc...

Surmodics to Webcast Third Quarter 2017 Earnings Conference Call on August 3

Webcast is Live at 7:30 a.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today ...

Surmodics to Webcast Fourth Quarter 2017 Earnings Conference Call on November 8

Webcast is Live at 7:30 a.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon

PREVEIL is a prospective, multi-center, single-arm clinical trial to assess the safety and functionality of the SurModics drug coated balloon (DCB) in the treatment of subjects with sympto...

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral an...

Companies [3 Associated Companies listed on BioPortfolio]

SurModics, Inc.

SurModics’ vision is to extend and improve the lives of patients through technology innovation. The Company partners with the world’s foremost medical device, pharmaceut...

Bringing Innovation Together

SurModics is a leading provider of surface modification and drug delivery solutions for the health care industry. One of SurModics’ core technology platforms is its patented drug-delivery polymer ma...

SurModics

Our Mission To enhance the well-being of our clients and their customers by providing the world's foremost innovative surface-modification technologies and related products. Our Guiding Principles ...

More Information about "SurModics" on BioPortfolio

We have published hundreds of SurModics news stories on BioPortfolio along with dozens of SurModics Clinical Trials and PubMed Articles about SurModics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SurModics Companies in our database. You can also find out about relevant SurModics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record